GPX4 is a critical regulator of ferroptotic cell death [11, 12]; inhibiting GPX4 activity has been shown to sensitize cancer cells to ferroptosis and may help overcome resistance to conventional therapies [13, 14]. This evidence concerns the gene GPX4 and cancer.